Wells Fargo Raises Globe Life (GL) Target, Keeps Overweight Rating

Core Viewpoint - Wells Fargo has raised the price target for Globe Life Inc. (GL) from $170 to $171 while maintaining an Overweight rating, indicating confidence in the company's performance despite a general lowering of earnings estimates across the sector [1]. Group 1: Analyst Ratings and Price Target - Wells Fargo analyst Elyse Greenspan increased the price target for Globe Life Inc. from $170 to $171 [1]. - As of February 27, 2026, 69% of 13 analysts covering Globe Life have assigned a Buy rating, with a 1-year median price target of $171 [3]. Group 2: Company Insights and Insider Activity - Globe Life Inc. is a provider of life and supplemental health insurance for middle-income families, founded in 1900 and headquartered in Texas [3]. - On February 9, 2026, Executive Vice President and Chief Strategy Officer Michael Clay Majors sold 30,000 shares of Globe Life stock, valued at $4,406,655, resulting in a -39% change in his ownership stake [2]. Group 3: Market Context - Wells Fargo is adjusting its valuation models to align with 2027 earnings and is introducing initial estimates for 2028, indicating a focus on long-term financial forecasting for the sector [1].